These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 15001275

  • 1. The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs.
    Beaulieu L, Archambault L, Aubin S, Oral E, Taschereau R, Pouliot J.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1298-308. PubMed ID: 15001275
    [Abstract] [Full Text] [Related]

  • 2. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.
    Mangili P, Stea L, Cattani F, Lappi S, Giglioli F, Calamia E, Ziglio F, Martinelli R, Longobardi B.
    Radiother Oncol; 2004 Apr 15; 71(1):13-21. PubMed ID: 15066291
    [Abstract] [Full Text] [Related]

  • 3. Effect of random seed placement error in permanent transperineal prostate seed implant.
    Bues M, Holupka EJ, Meskell P, Kaplan ID.
    Radiother Oncol; 2006 Apr 15; 79(1):70-4. PubMed ID: 16515813
    [Abstract] [Full Text] [Related]

  • 4. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
    Pickett B, Pouliot J.
    Med Dosim; 2004 Apr 15; 29(3):204-9. PubMed ID: 15324917
    [Abstract] [Full Text] [Related]

  • 5. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
    Su Y, Davis BJ, Furutani KM, Herman MG, Robb RA.
    Phys Med Biol; 2007 Jun 07; 52(11):3105-19. PubMed ID: 17505092
    [Abstract] [Full Text] [Related]

  • 6. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
    Ali I, Algan O, Thompson S, Sindhwani P, Herman T, Cheng CY, Ahmad S.
    Phys Med Biol; 2009 Sep 21; 54(18):5595-611. PubMed ID: 19717887
    [Abstract] [Full Text] [Related]

  • 7. Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy?
    Potters L, Calugaru E, Jassal A, Presser J.
    Int J Radiat Oncol Biol Phys; 2006 Jul 15; 65(4):1014-9. PubMed ID: 16682144
    [Abstract] [Full Text] [Related]

  • 8. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
    Raben A, Chen H, Grebler A, Geltzeiler J, Geltzeiler M, Keselman I, Litvin S, Sim S, Hanlon A, Yang J.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1631-8. PubMed ID: 15590195
    [Abstract] [Full Text] [Related]

  • 9. Can the cost of permanent prostate implants be reduced? An argument for peripheral loading with higher strength seeds.
    Maguire PD, Waterman FM, Dicker AP.
    Tech Urol; 2000 Jun 01; 6(2):85-8. PubMed ID: 10798805
    [Abstract] [Full Text] [Related]

  • 10. Prostate brachytherapy post-implant dosimetry: a comparison between higher and lower source density.
    Thomas CW, Kruk A, McGahan CE, Spadinger I, Morris WJ.
    Radiother Oncol; 2007 Apr 01; 83(1):18-24. PubMed ID: 17368844
    [Abstract] [Full Text] [Related]

  • 11. Toward a dynamic real-time intraoperative permanent prostate brachytherapy methodology.
    Potters L, Calguaru E, Thornton KB, Jackson T, Huang D.
    Brachytherapy; 2003 Apr 01; 2(3):172-80. PubMed ID: 15062140
    [Abstract] [Full Text] [Related]

  • 12. Dosimetric and volumetric criteria for selecting a source activity and a source type ((125)I or (103)Pd) in the presence of irregular seed placement in permanent prostate implants.
    Wuu CS, Ennis RD, Schiff PB, Lee EK, Zaider M.
    Int J Radiat Oncol Biol Phys; 2000 Jun 01; 47(3):815-20. PubMed ID: 10837969
    [Abstract] [Full Text] [Related]

  • 13. Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy.
    Wust P, von Borczyskowski DW, Henkel T, Rosner C, Graf R, Tilly W, Budach V, Felix R, Kahmann F.
    Radiother Oncol; 2004 Oct 01; 73(1):39-48. PubMed ID: 15465144
    [Abstract] [Full Text] [Related]

  • 14. AnchorSeed for the reduction of source movement in prostate brachytherapy with the Mick applicator implant technique.
    Badwan HO, Shanahan AE, Adams MA, Shanahan TG, Mueller PW, Markwell SJ, Tarter TH.
    Brachytherapy; 2010 Oct 01; 9(1):23-6. PubMed ID: 19762286
    [Abstract] [Full Text] [Related]

  • 15. Dose-volume conundrum for response of prostate cancer to brachytherapy: summary dosimetric measures and their relationship to tumor control probability.
    D'Souza WD, Thames HD, Kuban DA.
    Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1540-8. PubMed ID: 15050335
    [Abstract] [Full Text] [Related]

  • 16. Monte Carlo investigation of I-125 interseed attenuation for standard and thinner seeds in prostate brachytherapy with phantom validation using a MOSFET.
    Mason J, Al-Qaisieh B, Bownes P, Henry A, Thwaites D.
    Med Phys; 2013 Mar 01; 40(3):031717. PubMed ID: 23464312
    [Abstract] [Full Text] [Related]

  • 17. Dose homogeneity as a function of source activity in optimized I-125 prostate implant treatment plans.
    D'Souza WD, Meyer RR.
    Int J Radiat Oncol Biol Phys; 2001 Nov 15; 51(4):1120-30. PubMed ID: 11704337
    [Abstract] [Full Text] [Related]

  • 18. Variability of prostate brachytherapy pre-implant dosimetry: a multi-institutional analysis.
    Merrick GS, Butler WM, Wallner KE, Blasko JC, Michalski J, Aronowitz J, Grimm P, Moran BJ, McLaughlin PW, Usher J, Lief JH, Allen ZA.
    Brachytherapy; 2005 Nov 15; 4(4):241-51. PubMed ID: 16344253
    [Abstract] [Full Text] [Related]

  • 19. Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era?
    Kudchadker RJ, Swanson DA, Kuban DA, Lee AK, Bruno TL, Frank SJ.
    Int J Radiat Oncol Biol Phys; 2008 Oct 01; 72(2):623-7. PubMed ID: 18410998
    [Abstract] [Full Text] [Related]

  • 20. Idealized line source configuration for permanent 125I prostate implants.
    Leclerc G, Lavallée MC, Tubic D, Métivier J, Vigneault E, Beaulieu L.
    Radiother Oncol; 2004 Aug 01; 72(2):213-20. PubMed ID: 15297139
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.